Pharmaceutical Services Division, Ministry of Health Malaysia 1 CANCER DRUG COUNSELLING A Guide for Pharmacists 1stEdition, 2017 Pharmaceutical Services Division Ministry of Health, Malaysia
2 Pharmaceutical Services Division, Ministry of Health Malaysia DISCLAIMER This guide would serve as a handy reference for PHARMACIST ONLY and not as a complete drug information resource. It is NOTintended to replicate or replace the knowledge, skills and experience of trained oncology health professionals, nor is it a substitute for clinical judgement and advice. The nature of healthcare/drug information is that it is constantly evolving with ongoing research and clinical experience and is often subject to interpretation. While best effort has been made to ensure the accuracy of the information and recommendation presented, reader is advised that the contributors, editors, reviewers and publishers cannot be responsible for the continued updates of the information, of any errors or/and of any consequences arising from its application. ALL RIGHTS RESERVED This is a publication of the Pharmaceutical Services Division, Ministry of Health Malaysia (MOH). Enquiries are to be directed to the address below. Permission is hereby granted to reproduce information contained herein provided that such reproduction be given due acknowledgement and shall not modify the text. Pharmaceutical Services Division Ministry of Health Malaysia Lot 36, Jalan Universiti 46350 Petaling Jaya Selangor, Malaysia Tel: 603 - 7841 3200 Fax 603 - 7968 2222 Website:
Pharmaceutical Services Division, Ministry of Health Malaysia 3 PREFACE Providing pharmaceutical care to patients through education and counselling can contribute towards enhancing patients’ adherence to cancer drug therapy as well as to reduce medication related problems. The complexity of current cancer drug therapies has resulted in changes in the role hospital pharmacists play in their provision of care towards cancer patients today. It is an established fact that provision of the right information benefits patients through shared decision making, and can lead to a better quality of life, which is the aim of patient-oriented pharmaceutical care. The practice of hospital pharmacists may differ between facilities, but in general, oncology pharmacists are expected to be competent in both drug-oriented services and patient centred care. The move towards daycare and outpatient administration of chemotherapy has increased the necessity for accurate and thorough patient and family education to enable them to manage their medicines independently. This requires pharmacists to explain the self-care activities to ensure proper use of their medications and to be aware of possible adverse effects and remedial choices to be taken in order to minimise risks to the patients.